Elekta to provide Stockholm region with advanced cancer care
STOCKHOLM, February 26, 2018 – Elekta (EKTA-B.ST) announced today that it has signed an agreement with Stockholm City Council regarding equipping the cancer center and radiation therapy departments of Södersjukhuset (Stockholm South General Hospital or SöS) and New Karolinska Solna (NKS). The agreement follows the Letter of Intent signed on December 12, 2017.
Under the agreement, SöS will acquire in total four state-of-the-art Elekta Versa HD™ cancer treatment systems, including software. In addition, Elekta’s brachytherapy solutions with Flexitron® afterloaders will be used at NKS to help treat patients with various cancers, such as prostate, head & neck and gynecological cancers.
Elekta’s President and CEO, Richard Hausmann, says: “We are happy to help SöS improve their radiation therapy department with Elekta’s sophisticated Versa HD systems, and to deliver our superior brachytherapy solution to NKS. SöS is creating a focal point for cancer treatment in the Stockholm area and we are excited to be part of this development. Their investment in new Versa HD linear accelerators will give patients greater access to unrivaled radiation therapy.”
Elekta announced in December 2017 that it will fully equip the radiation therapy department of SöS and to provide brachytherapy solutions to New Karolinska Solna (NKS). The total value of this deal is SEK 160 million.
# # #
For further information, please contact:
Oskar Bosson, Global EVP Corporate Communications and Investor Relations
Tel: +46 70 410 7180, e-mail: [email protected]
Time zone: CET: Central European Time
Michelle Joiner, Director, Global Media Relations
Tel: +1 770 670 2447, e-mail: [email protected]
Time zone: ET: Eastern Time
About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com